Publication | Closed Access

Isoorientin attenuates doxorubicin-induced cardiac injury via the activation of MAPK, Akt, and Caspase-dependent signaling pathways

InflammationCardiac MuscleCardiomyopathyHeart FailureCardiovascular DiseaseCell SignalingMedicinePhysiologyCardiovascular PharmacologyCell DeathCaspase-dependent Signaling PathwaysDoxorubicin-induced Cardiac InjuryCardiovascular ToxicityPharmacologyCardiology